Mark43, formerly known as Nucleik, was founded in 2012 by Florian Mayr, Matthew Polega, and Scott Crouch. The company has not officially endorsed a plan to participate in an IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Mark43 is a public safety software company that partners with law enforcement agencies around the world to develop and apply data-driven solutions to all areas of the job. The company has raised more than $220 million in venture capital funding, most recently in a Series E equity round that brought in $101 million in new funding from investors including Spruce House Investment Management, Tiger Global Management, Avenir Capital, General Catalyst Partners, HighSage Ventures, Spark Capital, and Goldman Sachs Group, Inc. The latest round of funding resulted in a $1 billion post-money valuation.

Register for Details

For more details on financing and valuation for Mark43, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Mark43

Forge green plus iconForge green minus icon

What is Mark43's IPO price?

The IPO price for Mark43 will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Mark43?

Mark43 is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Mark43 shares pre-IPO?

If you own Mark43 pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Mark43 a publicly traded company?

Mark43 is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Mark43's funding to date?

Mark43 has raised $315.61MM to date.
Forge green plus iconForge green minus icon

When was Mark43 founded?

Mark43 was founded in 2012.

Who are Mark43's major investors?

Avenir Growth Capital
Gaingels
Bezos Expeditions
10X Capital

Mark43 Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
3/29/2024 Series F $55MM raised $XXX.XX $XXX.XX
7/12/2021 Series E and E-1 $101MM raised $XXX.XX $XXX.XX
4/21/2020 Series D $50MM raised $XXX.XX $XXX.XX
3/20/2018 Series C $69.52MM raised $XXX.XX $XXX.XX
4/26/2016 Series B $27MM raised $XXX.XX $XXX.XX
12/30/2015 Series A $11.14MM raised $XXX.XX $XXX.XX
7/15/2013 Series Seed $1.95MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.